Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Syneos Health, Inc. SYNH
$41.58
-$0.12 (-0.29%)
На 18:00, 12 мая 2023
+90.79%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
4292760780.00000000
-
week52high
79.77
-
week52low
22.89
-
Revenue
5393082000
-
P/E TTM
15
-
Beta
1.61903100
-
EPS
2.59000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 12:00
Описание компании
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Mizuho | Buy | Buy | 03 авг 2022 г. |
Barclays | Overweight | Overweight | 13 июл 2022 г. |
Guggenheim | Buy | 24 мая 2022 г. | |
Jefferies | Hold | Buy | 25 апр 2022 г. |
Deutsche Bank | Buy | 12 апр 2022 г. | |
Baird | Outperform | Outperform | 16 сент 2022 г. |
Guggenheim | Neutral | Buy | 14 сент 2022 г. |
Barclays | Overweight | Overweight | 12 сент 2022 г. |
UBS | Neutral | 07 сент 2022 г. | |
Barclays | Overweight | Overweight | 06 окт 2022 г. |
Citigroup | Neutral | Neutral | 05 окт 2022 г. |
Mizuho | Buy | Buy | 12 окт 2022 г. |
Deutsche Bank | Buy | Buy | 12 окт 2022 г. |
JP Morgan | Neutral | Overweight | 18 окт 2022 г. |
Citigroup | Neutral | Neutral | 07 ноя 2022 г. |
Barclays | Overweight | Overweight | 07 ноя 2022 г. |
Baird | Outperform | Outperform | 07 ноя 2022 г. |
Mizuho | Neutral | Buy | 14 дек 2022 г. |
Barclays | Underweight | Overweight | 17 янв 2023 г. |
Barclays | Underweight | Overweight | 13 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Kralowetz Donna Hildebrand | A | 21353 | 7064 | 19 янв 2023 г. |
Kralowetz Donna Hildebrand | D | 14289 | 211 | 18 янв 2023 г. |
Tucat Christian | D | 47946 | 679 | 18 янв 2023 г. |
Brooks Michael Lee | D | 7025 | 561 | 18 янв 2023 г. |
Brooks Michael Lee | D | 123082 | 1159 | 18 янв 2023 г. |
KEEFE MICHELLE | D | 190846 | 1118 | 18 янв 2023 г. |
Meggs Jason M. | D | 66061 | 866 | 18 янв 2023 г. |
Olefson Jonathan | D | 62104 | 936 | 18 янв 2023 г. |
Kralowetz Donna Hildebrand | D | 14500 | 557 | 17 янв 2023 г. |
Tucat Christian | A | 48625 | 16465 | 17 янв 2023 г. |
Institutional Ownership
Institutional Ownership
Holder | Shares | Change | Date Reported |
---|---|---|---|
DIMENSIONAL FUND ADVISORS LP | 1240809 | 219702 | 30 сент 2022 г. |
Vanguard Total Stock Market Index Fund | 2348520 | -23396 | 31 авг 2020 г. |
iShares Core S&P Mid-Cap ETF | 1656040 | -3520 | 31 авг 2020 г. |
iShares NASDAQ Biotechnology ETF | 1069220 | -10014 | 31 авг 2020 г. |
Vanguard Small-Cap Index Fund | 2070880 | -16720 | 31 июл 2020 г. |
Vanguard Small-Cap Growth Index Fund | 1258030 | -8085 | 31 июл 2020 г. |
JPMorgan Small Cap Equity Fund | 1237770 | 18834 | 31 июл 2020 г. |
Mackenzie US Small-Mid Cap Growth Class | 1951070 | 212048 | 30 июн 2020 г. |
ClearBridge Small Cap Growth Fund | 1569850 | 0 | 30 июн 2020 г. |
Vanguard Selected Value Fund | 1023100 | -88883 | 30 июн 2020 г. |
Новостная лента
Syneos Health (SYNH) Announces a $7.1 Billion Merger Agreement
Zacks Investment Research
11 мая 2023 г. в 10:39
Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a private investment consortium.
Syneos Health (SYNH) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
10 мая 2023 г. в 09:55
Syneos Health (SYNH) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $1.01 per share a year ago.
SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today
InvestorPlace
10 мая 2023 г. в 09:29
Syneos Health (NASDAQ: SYNH ) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal. A group of investors led by Elliott Investment Management intend to take the healthcare company private for a price of $43 per share.
Syneos Health Stock Rises on $7.1 Billion Sale to Private Group
Barrons
10 мая 2023 г. в 08:02
The sale of Syneos Health comes as the company faces muted spending from drug developers for its clinical-research services.
Syneos Health's stock soars 19% on acquisition report
Market Watch
09 мая 2023 г. в 16:40
Syneos Health Inc.'s SYNH stock surged 19% in extended trading Tuesday on a Bloomberg report that a consortium of Elliott Investment Management, Patient Square Capital and Veritas Capital is in advanced talks to acquire Syneos, a drug-research services company. A deal could be announced as soon as this week, according to people with knowledge of the talks, the report said.